Legal Representation
Attorney
Frances M. Jagla
USPTO Deadlines
Next Deadline
829 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2021-10-19)
Due Date
October 19, 2027
Grace Period Ends
April 19, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
44 eventsDate | Code | Type | Description |
---|---|---|---|
Nov 7, 2023 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
Nov 7, 2023 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
Nov 7, 2023 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Nov 7, 2023 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Nov 7, 2023 | ECDR | I | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
Nov 7, 2023 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Oct 19, 2021 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
Sep 15, 2021 | OP.D | T | OPPOSITION DISMISSED NO. 999999 |
Sep 15, 2021 | OP.T | T | OPPOSITION TERMINATED NO. 999999 |
Sep 15, 2021 | TMBN | T | TTAB RELEASE CASE TO TRADEMARKS |
Jun 10, 2021 | OP.I | T | OPPOSITION INSTITUTED NO. 999999 |
Jan 6, 2021 | ETOF | T | EXTENSION OF TIME TO OPPOSE RECEIVED |
Dec 15, 2020 | PUBO | A | PUBLISHED FOR OPPOSITION |
Dec 15, 2020 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Nov 25, 2020 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Nov 12, 2020 | FIXD | O | ELECTRONIC RECORD REVIEW COMPLETE |
Nov 6, 2020 | ERRR | O | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED |
Nov 5, 2020 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER |
Oct 28, 2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
Oct 28, 2020 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
Oct 27, 2020 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Oct 27, 2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Aug 13, 2020 | CNRT | R | NON-FINAL ACTION WRITTEN |
Aug 13, 2020 | GNRT | O | NON-FINAL ACTION E-MAILED |
Aug 13, 2020 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Jul 25, 2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Jul 25, 2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
Jul 21, 2020 | ERSI | I | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
Mar 23, 2020 | CNSL | R | SUSPENSION LETTER WRITTEN |
Mar 23, 2020 | GNSL | S | LETTER OF SUSPENSION E-MAILED |
Mar 23, 2020 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
Mar 10, 2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
Mar 9, 2020 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Mar 9, 2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Sep 10, 2019 | CNRT | R | NON-FINAL ACTION WRITTEN |
Sep 10, 2019 | GNRT | F | NON-FINAL ACTION E-MAILED |
Sep 10, 2019 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Sep 3, 2019 | DOCK | D | ASSIGNED TO EXAMINER |
Jul 1, 2019 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Jul 1, 2019 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
Jun 25, 2019 | ALIE | A | ASSIGNED TO LIE |
Jun 24, 2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Jun 19, 2019 | PARI | I | TEAS VOLUNTARY AMENDMENT RECEIVED |
Jun 14, 2019 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 001
Plant extracts for medical and pharmaceutical research purposes
First Use Anywhere:
0
First Use in Commerce:
0
Class 005
Nutritional additives for medical purposes in the nature of natural food extracts derived from herbs, fruits, spices, vegetables, algae, fungi; nutritional food additives for medical purposes in the nature of natural food extracts derived from meat, fish, poultry and game, meat extracts, fruit and canned vegetables, dried and cooked, jellies, jams, compotes, eggs, milk and milk products, edible oils and fats; phytopharmaceuticals for the treatment of autoimmune, immune, viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and intestinal, bowel diseases, disorders and conditions; plant extracts for medical purposes; pharmaceutical for the treatment of human diseases, disorders and conditions, namely, autoimmune, immune, viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and intestinal, bowel diseases, disorders and conditions; sanitary preparations for medical use; dietetic food, namely, herbs, fruits, spices, vegetables, algae, fungi; dietetic food, namely, food for babies; adjuvants for medical purposes; amino acids for medical purposes; anaesthetics; analgesics; vermifuges; antibiotics; biological preparations for the treatment of human diseases, disorders and conditions, namely, autoimmune, immune, viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and intestinal, bowel diseases, disorders and conditions; chemical active components for medical use, namely, chemical preparations for treating genetic conditions, rare diseases and conditions, namely, autoimmune, immune, viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and intestinal, bowel diseases, disorders and conditions; chemical reagents for medical or veterinary purposes; chemico-pharmaceutical preparations for the treatment of human diseases, disorders and conditions, namely, autoimmune, immune, viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and intestinal, bowel diseases, disorders and conditions; ferments for pharmaceutical purposes; hormones for medical purposes; medical infusions for the treatment of human diseases, disorders and conditions, namely, autoimmune, immune, viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and intestinal, bowel diseases, disorders and conditions; medicines for the treatment of gum disease, caries, toothache and wound healing of the gums; medicines for the treatment of human diseases, disorders and conditions, namely, autoimmune, immune, viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and intestinal, bowel diseases, disorders and conditions; radiological contrast substances for medical purposes; steroids; none of the foregoing goods for dermatological or plaque psoriasis applications or in the field of dermatological or plaque psoriasis diseases, disorders and conditions
First Use Anywhere:
0
First Use in Commerce:
0
Class 010
Medical diagnostic apparatus for detecting diseases, disorders and conditions, namely, autoimmune, immune, viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and intestinal, bowel diseases, disorders and conditions; Surgical apparatus and instruments for medical or veterinary use; Surgical and medical apparatus and instruments for use in orthopedic surgery; Medical and surgical apparatus and instruments, namely, orthopedic apparatus and instruments for diagnostic and therapeutic use; Medical and surgical apparatus, medical instruments for use in treating genetic conditions, rare diseases and conditions, namely, autoimmune, immune, viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and intestinal, bowel diseases, disorders and conditions; orthopaedic articles, namely, orthopedic devices for diagnostic and therapeutic use; orthopaedic articles, namely, vertebral orthopedic apparatus; suture materials; therapeutic and assistive devices adapted for the disabled, namely, motion sensing apparatus and assisted machines for the rehabilitation of hands and wrists, feet and ankles, knees, spine affected by neuromuscular diseases, disorders, or injuries for home or clinical use; massage apparatus; Medical and surgical apparatus and instruments, namely, orthopedic fixation device used in orthopedic transplant and/or implant surgery
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
Scientific research, technological development of new products for others; medical research; scientific and industrial research in the fields of biotechnology, biology, rare diseases and conditions, genetic conditions and treatments of rare diseases and conditions; industrial research in the field of biomedical and phytopharmaceutical engineering; pharmaceutical laboratory services; pharmaceutical research and development; scientific services, namely, development of drugs, active agents and vaccines; scientific services, namely, development of food supplements; development of pharmaceutical preparations and medicines; development of pharmaceuticals and medicines and plant extracts for use in pharmaceutical preparations and medicines
First Use Anywhere:
0
First Use in Commerce:
0
Class 044
Consulting on medicines, namely, medical and pharmaceutical consultation
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
001
005
010
042
044